General Medicine July 2021 Bimonthly blended assessment

Question 1

 Competency tested for Peer to peer review and assessment :


I'm sharing my review on the above link of elog of last month assessment done by one of my batchmate and I felt it is well and clean presentation of individual's thoughts and detail enough coming to discussing the cases.And I have to thank for giving a better idea on the assessment and making realize the mistakes I did in understanding the same assessment.

Question 2:


 The link to your own case report of a patient that you connected with and engaged while capturing his her sequential life events before and after the illness and clinical and investigational images along with your discussion of that case


The above link is of  elog done by me with help of Intern on patient of 18 years old female came with cheif complaints of weakness in both the lower limbs and unable to stand on her own without support
 H/o Seizure episode and weakness of both lower limbs
Was unable to walk without support till 6 years of age
Faced difficulty in studying and writing at 6 years
Was able to do work at home by 8 years since then unable to do heavy work
At 15 years attained normal growth and normal milestones
2 months back developed sudden onset of oedema which relieved on rest.

One morning ,went for urination & Suddenly she is unable to get her on her own ,on visiting local hospital diagnosed with Hypokalemic periodic paralysis.

Then she took herbal medicine for 10 days and able to get on her own with support,and developed nausea ,vomiting 2-3 episodes ,then on visiting hospital diagnosed with Dyselectrolytemia.
Then Outside MRI showing B/L Mild cerebellar & vermian atropy .
The atrophy may be the reason for spastic gait and on examination there is decreased HMF ,positive Romberg's sign and also hypertonia in both lower limbs  investigations show resolved hypokalemia.
And diagnosed as spastic paraperesis secondary to perinatal insult & peripheral neuropathy distal>promixal.
The treatment is monitoring the serum electrolytes and drugs to reduce spasticity
And physical exercise.


Question 3:


 Testing peer review competency of the examinees:Please go through the cases in the links below & provide your critical appraisal of the captured data in terms of completeness, correctness and ability to provide useful leads to analyze the diagnostic and therapeutic uncertainties around the cases shared

Case 1: AKI 

Review: The case is well presented from History taking to the treatment and it is in order and made easy to read and understand in better way.And the radiographic investigation is also clearly shown.

Case 2:CKD


Review:
The case was presented in a easy and more information was given , a thorough history taking has been done and the case is well explained using all the pictures of investigations and reports.

Case 3:Patient with coma and renal failure


Review:
Both the above elogs are detail enough to understand the case and the videos and photos are clear and especially in first case they also showing the condition of patient corresponding with treatment.They are really appreciably presented.

Case 4: patient with AKI


Review: The case is Alcoholic hepatitis and AKI secondary to gastroenteritis and the history of the present illness is well described and the investigations ,examination and treatment plan is well presented.

Case 5:Patient with acute on CKD


Review:The case presentation is very good. The diagrams helped in understanding. 

Question 4:

Testing scholarship competency of the examinees ability to read ,comprehend, analyze the above linked patient data by first preparing a problem list for each patient and then discuss the diagnostic and therapeutic uncertainty around solving those problems. Also include the review of literature around sensitivity and specificity of the diagnostic interventions mentioned and same around efficacy of the therapeutic interventions.


Chronic kidney disease (CKD)—or chronic renal failure (CRF), as it was historically termed—is a term that encompasses all degrees of decreased kidney function, from damaged–at risk through mild, moderate, and severe chronic kidney failure.

The guidelines define CKD as either kidney damage or a decreased glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m2 for at least 3 months. Whatever the underlying etiology, once the loss of nephrons and reduction of functional renal mass reaches a certain point, the remaining nephrons begin a process of irreversible sclerosis that leads to a progressive decline in the GFR.

Staging:

Stage 1: Kidney damage with normal or increased GFR (>90 mL/min/1.73 m2)

Stage 2: Mild reduction in GFR (60-89 mL/min/1.73 m2)

Stage 3a: Moderate reduction in GFR (45-59 mL/min/1.73 m2)

Stage 3b: Moderate reduction in GFR (30-44 mL/min/1.73 m2)

Stage 4: Severe reduction in GFR (15-29 mL/min/1.73 m2)

Stage 5: Kidney failure (GFR < 15 mL/min/1.73 m2 or dialysis).

Diagnosis:

By itself, measurement of GFR may not be sufficient for identifying stage 1 and stage 2 CKD, because in those patients the GFR may in fact be normal or borderline normal. In such cases, the presence of one or more of the following markers of kidney damage can establish the diagnosis.

Albuminuria (albumin excretion > 30 mg/24 hr or albumin:creatinine ratio > 30 mg/g [> 3 mg/mmol])

Urine sediment abnormalities

Electrolyte and other abnormalities due to tubular disorders

Histologic abnormalities

Structural abnormalities detected by imaging

History of kidney transplantation in such cases

Signs and symptoms:

Signs of alterations in the way the kidneys are handling salt and water in stage 5 include the following:

  • Peripheral edema

  • Pulmonary edema

  • Hypertension.

Laboratory studies used in the diagnosis of CKD can include the following

  • Complete blood count (CBC)

  • Basic metabolic panel

  • Urinalysis

  • Serum albumin levels: Patients may have hypoalbuminemia due to malnutrition, urinary protein loss, or chronic inflammation

  • Lipid profile: Patients with CKD have an increased risk of cardiovascular disease.

  • Imaging studies also done accordingly.

Mangement:

Delaying or halting the progression of CKD: Treatment of the underlying condition, if possible, is indicated

Diagnosing and treating the pathologic manifestations of CKD

Timely planning for long-term renal replacement therapy

Acute kidney injury (AKI)—or acute renal failure (ARF), This condition is usually marked by a rise in serum creatinine concentration or by azotemia (a rise in blood urea nitrogen [BUN] concentration).[1]However, immediately after a kidney injury, BUN or creatinine levels may be normal, and the only sign of a kidney injury may be decreased urine production.

A rise in the creatinine level can result from medications (eg, cimetidine, trimethoprim) that inhibit the kidney’s tubular secretion, while a rise in the BUN level can also occur without renal injury, resulting instead from such sources as gastrointestinal (GI) or mucosal bleeding, steroid use, or protein loading. Therefore, a careful inventory must be taken before concluding that a kidney injury is present.

AKI may be classified into 3 general categories, as follows:

Prerenal - As an adaptive response to severe volume depletion and hypotension, with structurally intact nephrons

Intrinsic - In response to cytotoxic, ischemic, or inflammatory insults to the kidney, with structural and functional damage

Postrenal - From obstruction to the passage of urine.

Diagnosis:

The following tests can aid in the diagnosis and assessment of AKI:

  • Kidney function studies: Increased levels of blood urea nitrogen (BUN) and creatinine are the hallmarks of renal failure; the ratio of BUN to creatinine can exceed 20:1 in conditions that favor the enhanced reabsorption of urea, such as volume contraction (this suggests prerenal AKI)

  • Complete blood count (can indicate infection; acute blood loss or chronic anemia; thrombotic microangiopathy)

  • Peripheral smear (eg, schistocytes such as hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura)

  • Serologic tests: These may show evidence of conditions associated with AKI, such as in lupus nephritis, ANCA vasculitis or anti-GBM disease or syndrome

  • Complement testing: Pattern may indicate AKI related to endocartis or various glomerulonephritidites

  • Fractional excretion of sodium and urea in the setting of oliguria

  • Bladder pressure: Patients with a bladder pressure above 25 mm Hg should be suspected of having AKI caused by abdominal compartment syndrome

  • Ultrasonography: Renal ultrasonography is useful for evaluating existing renal disease and obstruction of the urinary collecting system

  • Aortorenal angiography : Can be helpful in establishing the diagnosis of renal vascular diseases, such as renal artery stenosis, renal atheroembolic disease, atherosclerosis with aortorenal occlusion, and certain cases of necrotizing vasculitis (eg, polyarteritis nodosa)

  • Renal biopsy: Can be useful in identifying intrarenal causes of AKI and directing targeted therapy


Treatment:

Maintenance of volume homeostasis and correction of biochemical abnormalities remain the primary goals of treatment and may include the following measures:

  • Correction of fluid overload with furosemide

  • Correction of severe acidosis with bicarbonate administration, which can be important as a bridge to dialysis

  • Correction of hyperkalemia

  • Correction of hematologic abnormalities (eg, anemia, uremic platelet dysfunction) with measures such as transfusions and administration of desmopressin or estrogens


Question 5:

Testing scholarship competency in logging reflective observations on your concrete experiences of this last month :

Experiencing the assessment in the form of elogs and exposing to clinical aspects and going through the problems of patients and seeing efforts put by doctors present there solving the case,I realized to make more effort in understanding the case.The importance of inculcating the knowledge of books in practice especially the history taking ,general examination  and their importance in pointing towards the source of the disease in patient and conserving valuable resources.And I have to say that I had better understanding about the elogs and this online communication and learning process than last month.And the Telemedical learning experience,eventhough it was found helpful in community at present situations of pandemic ,I felt it lack some psychological aspects in doctor patient interaction.The most interesting and enthusiastic aspect brought to me by this elogs is going through different journals where fascinating and unique ideas of individual's I came across  and their contributions in bringing a better outcome in various fields of Medicine.

Thank you

Soumya Menda

Roll no. 80.


Popular posts from this blog

29 year old with bilateral lower limb pain

OSCE questions

18 Y FEMALE WITH WEAKNESS IN LOWER LIMBS